Your browser doesn't support javascript.
loading
Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases.
Palmer, Joshua D; Prasad, Rahul N; Fabian, Denise; Wei, Lai; Yildiz, Vedat O; Tan, Yubo; Grecula, John; Welliver, Meng; Williams, Terence; Elder, James B; Raval, Raju; Blakaj, Dukagjin; Haglund, Karl; Bazan, Jose; Kendra, Kari; Arnett, Andrea; Beyer, Sasha; Liebner, David; Giglio, Pierre; Puduvalli, Vinay; Chakravarti, Arnab; Wuthrick, Evan.
Afiliação
  • Palmer JD; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA. Electronic address: Joshua.Palmer@osumc.edu.
  • Prasad RN; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Fabian D; Department of Radiation Oncology, University of Kentucky Markey Cancer Center, Lexington, USA.
  • Wei L; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Yildiz VO; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Tan Y; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Grecula J; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Welliver M; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Williams T; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Elder JB; Department of Neurosurgery, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Raval R; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Blakaj D; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Haglund K; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Bazan J; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Kendra K; Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Arnett A; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Beyer S; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Liebner D; Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Giglio P; Department of Neuro Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Puduvalli V; Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, USA.
  • Chakravarti A; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Wuthrick E; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, USA.
Radiother Oncol ; 170: 21-26, 2022 05.
Article em En | MEDLINE | ID: mdl-35367525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Radiocirurgia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Radiocirurgia Idioma: En Ano de publicação: 2022 Tipo de documento: Article